The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack "MENA-TIA"

Not yet recruiting

Phase 4 Results N/A

Summary of Purpose

The primary goal of the research is to determine if 10 days of dual anti-platelet treatment is as effective as 30 days of similar treatment in the prevention of stroke, myocardial ischemia (MI) and death in patients with TIAs and minor stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 December 2014.

1 Jul 2014 17 Apr 2014 1 Jun 2018 1 Oct 2018 1 Dec 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment